BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16636680)

  • 1. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
    Merzianu M; Jiang L; Lin P; Wang X; Weber DM; Vadhan-Raj S; Nguyen MH; Medeiros LJ; Bueso-Ramos CE
    Mod Pathol; 2006 Jul; 19(7):891-8. PubMed ID: 16636680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
    Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nodal lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: a clinicopathological and prognostical study].
    Zhang DD; Hu PZ; Li P; Jiang GZ; Yin YH; Wang GN; Zhao WG; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):592-597. PubMed ID: 34078045
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
    Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
    Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
    Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
    Front Immunol; 2022; 13():903315. PubMed ID: 36172352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma].
    Zou D; Yi S; Liu H; Li Z; Lyu R; Liu W; Ru K; Zhang P; Chen H; Qi J; Zhao Y; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):493-6. PubMed ID: 26134015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
    Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of Waldenström macroglobulinemia.
    McMaster ML
    Semin Hematol; 2023 Mar; 60(2):65-72. PubMed ID: 37099032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
    Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
    Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma].
    Yu Y; Xiong WJ; Chen JW; Jiao Y; Yan YT; Wang Q; Zou DH; Liu W; Liu HM; Lyu R; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):568-574. PubMed ID: 36709134
    [No Abstract]   [Full Text] [Related]  

  • 11. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
    Brunner A; Thalhammer-Thurner GC; Willenbacher W; Haun M; Zelger BG; Willenbacher E
    Ann Hematol; 2024 Feb; 103(2):553-563. PubMed ID: 37951851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Non-IgM Lymphoplasmacytic Lymphoma with Unusual Lack of Immunoglobulin Light Chain Production.
    Yin J; Bains A; Alsammak M; Fu JJ
    Am J Case Rep; 2024 Mar; 25():e940963. PubMed ID: 38437184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
    Cholujova D; Beke G; Hunter ZR; Hideshima T; Flores L; Zeleznikova T; Harrachova D; Klucar L; Leiba M; Drgona L; Treon SP; Kastritis E; Dorfman DM; Anderson KC; Jakubikova J
    Int J Cancer; 2023 May; 152(9):1947-1963. PubMed ID: 36533670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A SCID-hu in vivo model of human Waldenström macroglobulinemia.
    Tassone P; Neri P; Kutok JL; Tournilhac O; Santos DD; Hatjiharissi E; Munshi V; Venuta S; Anderson KC; Treon SP; Munshi NC
    Blood; 2005 Aug; 106(4):1341-5. PubMed ID: 15886318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoplasmacytic lymphoma with IgG-κ paraproteinemia presenting as a hepatic bulky mass.
    Higuchi M; Senoo T; Morita C; Furugo I; Hamada T; Ohshima K
    J Clin Exp Hematop; 2022; 62(4):273-278. PubMed ID: 36575005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis].
    Takarada A; Momose H; Kurita N; Matsuoka R; Nakamura N; Sakamoto T; Kato T; Hattori K; Suehara Y; Yokoyama Y; Nishikii H; Maruyama Y; Obara N; Chiba S; Sakata-Yanagimoto M
    Rinsho Ketsueki; 2023; 64(1):54-59. PubMed ID: 36775308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of diffuse large B-cell lymphoma, acute myeloid leukemia, and untreated lymphoplasmacytic lymphoma/waldenström macroglobulinemia in a same patient: A case report.
    Zhang LB; Zhang L; Xin HL; Wang Y; Bao HY; Meng QQ; Jiang SY; Han X; Chen WR; Wang JN; Shi XF
    World J Clin Cases; 2023 Jun; 11(18):4295-4305. PubMed ID: 37449216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
    Kumar SK; Callander NS; Adekola K; Anderson LD; Baljevic M; Baz R; Campagnaro E; Castillo JJ; Costello C; D'Angelo C; Derman B; Devarakonda S; Elsedawy N; Garfall A; Godby K; Hillengass J; Holmberg L; Htut M; Huff CA; Hultcrantz M; Kang Y; Larson S; Lee H; Liedtke M; Martin T; Omel J; Robinson T; Rosenberg A; Sborov D; Schroeder MA; Sherbenou D; Suvannasankha A; Valent J; Varshavsky-Yanovsky AN; Snedeker J; Kumar R
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e240001. PubMed ID: 38244272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenstrom macroglobulinemia involving the superior rectus muscle.
    Hellman JB; Harocopos GJ; Lin LK
    Am J Ophthalmol Case Rep; 2018 Jun; 10():304-306. PubMed ID: 29780960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
    Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
    J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.